Cardiological aspects of stroke prevention

Area of Science:

• Cardiology
• Neurology
• Stroke Medicine

Background:

• Cardiac disorders increase stroke risk (ischemic and hemorrhagic).
• Atrial fibrillation (AF) is a primary cardiac cause of ischemic stroke (IS).
• Occult AF detection rises with implantable cardiac monitors post-IS.

Purpose of the Study:

• To inform cardiologists about advances in stroke prevention for cardiac patients.
• To review stroke risk factors and prevention strategies in various cardiac conditions.

Main Methods:

• Review of current literature on cardiac disorders and stroke risk.
• Analysis of new oral anticoagulants versus warfarin for stroke prevention in AF.
• Evaluation of stroke risk in specific conditions like cardiomyopathy and patent foramen ovale.

Main Results:

• New oral anticoagulants show reduced IS and intracerebral hemorrhage risk versus warfarin in AF.
• Implantable monitors improve detection of AF after IS.
• Stroke risk is elevated in patients with cardiomyopathy, valve replacement, myocardial infarction, aortic atheroma, and PFO.

Conclusions:

• New oral anticoagulants offer improved safety and efficacy for stroke prevention in AF.
• Optimal IS prevention strategies for non-AF cardiac disorders require further research and individualized approaches.
• Cardiologists must integrate stroke prevention into the management of diverse cardiac conditions.